Cargando…
Anti-inflammation-based treatment of atherosclerosis using Gliclazide-loaded biomimetic nanoghosts
In the study, a biomimetic platform for anti-inflammatory-based treatment of atherosclerotic plaque was developed. Gliclazide (GL) as an anti-inflammasome agent was encapsulated in PLGA nanoparticles (NP), which were coated by monocyte membrane using an extrusion procedure. The size and zeta potenti...
Autores principales: | Karami, Zahra, Mehrzad, Jalil, Akrami, Mohammad, Hosseinkhani, Saman |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10449813/ https://www.ncbi.nlm.nih.gov/pubmed/37620556 http://dx.doi.org/10.1038/s41598-023-41136-y |
Ejemplares similares
-
Reprogramming of macrophages with macrophage cell membrane-derived nanoghosts
por: Hwang, Jangsun, et al.
Publicado: (2020) -
Bioavailability and Antidiabetic Activity of Gliclazide-Loaded Cubosomal Nanoparticles
por: Nasr, Mohamed, et al.
Publicado: (2021) -
Pharmacokinetics and Anti-Diabetic Studies of Gliclazide Nanosuspension
por: Sampathi, Sunitha, et al.
Publicado: (2022) -
Nano-biomimetic carriers are implicated in mechanistic evaluation of intracellular gene delivery
por: Alipour, Mohsen, et al.
Publicado: (2017) -
CaZnO-based nanoghosts for the detection of ssDNA, pCRISPR and recombinant SARS-CoV-2 spike antigen and targeted delivery of doxorubicin
por: Rabiee, Navid, et al.
Publicado: (2022)